Baxter plotting dialysis strategy to compete with Fresenius/NMC combination.
This article was originally published in The Gray Sheet
Executive Summary
BAXTER PURSUING ALTERNATIVES TO NMC ACQUISITION after withdrawing its $3.8 bil. bid for National Medical Care in a Feb. 22 letter to W.R. Grace Chairman, President and CEO Albert Costello. Baxter says it is now considering alternatives for its dialysis business to compete with what likely will be a combined Fresenius/NMC dialysis services and supplies operation.